We propose that increased levels of oxidative stress lead to a neuronal DDR, which is associated with the down‐regulation of insulin/IGF and Wnt signalling, resulting in increased GSK3β activity and ultimately leading to neuronal dysfunction and cognitive impairment, independent of local Alzheimer‐type pathology in the ageing brain. Here, GSK3B is linked to Cognitive impairment.